hydroxychloroquine has been researched along with vitamin k semiquinone radical in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kher, A; Toulemonde, F | 1 |
| Belizna, C; Camarzana, A; Jaquinandi, V; Le Tourneau, T; Mahe, G; Mezdad, TH; Omarjee, L; Rouleau, F | 1 |
| Belfeki, N; Declerck, D; Diamantis, S; Shankarasivam, G | 1 |
1 review(s) available for hydroxychloroquine and vitamin k semiquinone radical
| Article | Year |
|---|---|
[Prevention of postoperative thrombo-embolic complications. The principal methods, other than low-dose heparin].
Topics: Anticoagulants; Dextrans; Dipyridamole; Femoral Neck Fractures; Heparin; Hip Joint; Humans; Hydroxychloroquine; Joint Prosthesis; Postoperative Complications; Risk; Thromboembolism; Thrombophlebitis; Vitamin K | 1977 |
2 other study(ies) available for hydroxychloroquine and vitamin k semiquinone radical
| Article | Year |
|---|---|
Improvement of Libman-Sacks Endocarditis With Combined Hydroxychloroquine-Vitamin K Antagonist Therapy in a Primary Antiphospholipid Syndrome Patient.
Topics: Anticoagulants; Antiphospholipid Syndrome; Antirheumatic Agents; Drug Therapy, Combination; Endocarditis; Follow-Up Studies; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Treatment Outcome; Vitamin K; Warfarin; Young Adult | 2018 |
Autoimmune myelofibrosis: a rare haematological involvement in systemic lupus erythematosus.
Topics: Adult; Anti-Inflammatory Agents; Antiphospholipid Syndrome; Antirheumatic Agents; Autoimmune Diseases; Diagnosis, Differential; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Pancytopenia; Prednisone; Primary Myelofibrosis; Sjogren's Syndrome; Treatment Outcome; Vitamin K | 2019 |